Healthcare -
Biotechnology - NASDAQ - US
$ 1.06
7.86 %
$ 74.6 M
Market Cap
-1.58
P/E
SLS - CHANGE IN WORKING CAPITAL
Change in Working Capital SLS - SELLAS Life Sciences Group, Inc.
3.34 M
LAST VALUE
56.18%
2 YEAR CAGR
18.48%
5 YEAR CAGR
2.92%
10 YEAR CAGR